As global regulatory expectations evolve, Sexton Biotechnologies is there to meet the challenge. With a validated pathogen reduction technology, nLiven PR established the gold standard for performance and quality of irradiated pooled human platelet lysate.
Validated pathogen reduction technology using E-Beam irradiation
Available in 100, 500 ml
Large donor pool lot sizes
Manufactured from outdated FDA/AABB approved apheresis platelet units
FDA master file, PMDA Certificate of Suitability
Used for manufacturing in US, EU, and other clinical trials globally
Manufactured under a certified ISO 9001:2015 Quality Management System